Holly Laughlin

Holly Laughlin is an accomplished finance professional with extensive experience in accounting and financial management. Currently serving as Corporate Controller at Cytokinetics since March 2019, Holly previously held leadership positions including Assistant Corporate Controller at Exelixis and Sr. Director of Accounting Operations at Medivation. Additional roles include Senior Director of North America Accounting at Gilead Sciences, Director of Accounting at Oracle, Director of External Reporting & WW Accounting at BEA Systems, and Director of WW Revenue Recognition at Hyperion Solutions. Holly began their career as a Manager in Audit at PriceWaterhouseCoopers. Educated at the University of Southern California with a Master's in Accounting and the University of California, Santa Cruz with a Bachelor's in Economics, Holly possesses a solid academic foundation for their professional achievements.